Trade Summary

5 months ago, Kim Helen Susan, serving as Dir, 10% owner at Aktis Oncology, Inc. (AKTS), purchased 835,000 shares at $18.00 per share, for a total transaction value of $15,030,000.00. Following this transaction, Kim Helen Susan now holds 157,387 shares of AKTS.

This purchase represents a 123.00% decrease in Kim Helen Susan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 12, 2026 at 12:00 PM ET, meaning the disclosure happened on the same day as the trade.

Aktis Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.